Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

BACKGROUND: Long term serum urate (SU) lowering to a target of <0.36 mmol/l (6 mg/dl) is recommended for effective gout management. However, many studies have reported low achievement of SU targets. The aim of this cross-sectional study was to examine the clinical and psychological factors associ...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Dalbeth, Nicola, House, Meaghan E, Horne, Anne, Petrie, Keith J, McQueen, Fiona M, Taylor, William J
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2012
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3493372/
https://ncbi.nlm.nih.gov/pubmed/22978848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-13-174
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы